µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£© i7 YUyU
a7u*d`3X=
Ò»¡¢Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© I*cb\eU8Y
1¡¢Co-stimulators (or co-stimulating molecules) upeioC q
2¡¢NK-kB wzoT!-_X
3¡¢Immunoglobulin superfamily Lrr(7cH,
4¡¢antigen-presenting cell (APC) `}$bJCSF.n
5¡¢death domain <KCyXU*
6¡¢CCR and CXCR .Xe_Gp"x
7¡¢Lectin (or mitogen) ;Kg7}4`I
8¡¢Clusters of differentiation, CD) SXJjagAoML
9¡¢B7 family }K,3SO(:
10¡¢Cytotoxic T lymphocyte, CTL) [4dX[
11¡¢IL-15 and IL-15 receptor (IL-15R) ;}ThBb3
12¡¢MHC restriction Y;g\ @j
13¡¢Affinity-chromatography -GB,g=Dk
14¡¢Cyctosprin A, CsA psz0q
|
15¡¢Antibody-dependent cell-mediated cytotoxicity, ADCC) Up_"qD6
(q}LirR
¶þ¡¢¼ò´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© "K+EZ%~<
1¡¢ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 *1_Ef).
2¡¢ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØϵ¡£ ,69547#o
3¡¢ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌص㡣 c"1Z,M;G
m] -cRf)9
Èý¡¢ÎÊ´ðÌ⣨25·Ö£© `YMd0*
1¡¢Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ `}bvbvmA
ѪҺ²¡Ñ§×¨Òµ£º ;, \!&o6
2¡¢ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎΪÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿